Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

MariMed Inc. (MRMD)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.8280-0.0324 (-3.76%)
At close: 03:59PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.8604
Open0.8700
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.8200 - 0.8700
52 Week Range0.6000 - 1.2000
Volume554,060
Avg. Volume648,917
Market Cap275.844M
Beta (5Y Monthly)3.45
PE Ratio (TTM)16.56
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for MRMD

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • MARIMED INC
    Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We CoverThis edition features European banks; California utilities; traditional payment firms; and notes from Johnson & Johnson, Green Thumb Industries, and new coverage Lithium Americas.
    Rating
    Fair Value
    Economic Moat
    2 months agoMorningstar
View more
  • Market Exclusive

    Weekly Roundup on the Cannabis Sector & Psychedelic Sector

    Key Takeaways; Cannabis Sector Ascend Wellness openly called out MedMen for abruptly canceling their binding agreement to acquire MedMen’s New York operations. ScottsMiracle-Gro expands Hawthorne Gardening portfolio with acquisitions of Luxx Lighting and True Liberty Bags. MariMed announced agreement to acquire Kind Therapeutics; a Maryland licensed vertically integrated cannabis business. Key Takeaways; Psychedelic Sector New […] The post Weekly Roundup on the Cannabis Sector & Psychedelic Sect

  • Motley Fool

    3 Top Cannabis Stocks to Buy for December

    These operators are profitable, growing businesses that all cannabis investors should consider loading up on today.

  • Benzinga

    MariMed: 213% YoY Increase In Q3 Adjusted EBITDA, Reaffirms Full-Year Revenue Guidance Of $118M

    Multi-state cannabis operator MariMed, Inc. (OTCQX: MRMD) reported its financial and operating results Monday for the quarter ended September 30. Q3 2021 Financial Highlights Revenue totaled $33.2 million, representing an increase of 147% from the third quarter of 2020. Gross profit was $18.2 million, an increase of 109% from the third quarter of 2020. Adjusted EBITDA, s non-GAAP measure, of $12.9 million, a 213% increase from the third quarter of 2020. Net income of $2.1 million, a 25% increase

Advertisement
Advertisement